Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with polymyalgia rheumatica (PMR)
COMMERCIAL CLINICAL TRIAL
Clinical trial information
- Promoter: SANOFI AVENTIS RECHERCHE & DEVELOPMENT
- Phase: III
- Execution start: 16/01/2020
- End of execution: 30/06/2021
- IP: RAFAEL CALIZ CALIZ